Neurotrope Alzheimer's Candidate Could Generate Revenue Beginning In 2024, Analyst Says
March 09, 2018 at 10:21 AM EST
Alzheimer's drug research has a high failure rate, and symptoms of the disease start appearing long after amyloid plaques — ...